SLE is a chronic and complex heterogeneous autoimmune disease in which the immune system dysfunctions and inappropriately ...

Rheumatology Advisor interviewed Fiona Watt, PhD, to discuss the relationship between menopause and rheumatic disease.

New York, NY. November 6, 2024. The Lupus Research Alliance (LRA) is excited to announce the first-ever recipients of the Translational Bridge Award (TBA), established this year to accelerate the ...

There is a clinical study underway that is testing whether an investigational medicine is safe and whether it may work for ...

“Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease where the immune system mistakenly attacks healthy tissues and organs. This can lead to a range of symptoms including joint pain, ...

Kikuchi–Fujimoto disease (KFD), histiocytic necrotising lymphadenitis, is a benign and self-limiting disease characterised ...

The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, myasthenia gravis and other conditions traced to misdirected immune response.

Estimates from the Lupus Foundation of America indicate roughly five million people across the globe have a form of lupus. Though that figure suggests a person’s chances of developing lupus are ...

A Fierce 15 winner last year, Ventus said its drug, VENT-03, “was safe and well-tolerated at doses far exceeding those planned for use in Phase 2 trials.” The drug’s "favorable PK profile” supports ...

Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced the upcoming presentation of preclinical data for ...